Loading organizations...

§ Private Profile · San Francisco, CA, USA
Woebot Health is a technology company.
Woebot Health develops AI-powered conversational agents that deliver digital therapeutic interventions for mental health. Their solutions leverage natural language processing and advanced algorithms to engage users in helpful dialogues, providing accessible and personalized support. These tools facilitate personal growth by offering timely care for various mental health challenges.
The company was founded in 2017 by Dr. Alison Darcy, a clinical research psychologist. Her foundational insight was that artificial intelligence could significantly expand the reach of evidence-based psychological support, addressing critical gaps in mental healthcare access. Her expertise in clinical psychology and technology led to the creation of their intelligent therapeutic platform.
Woebot Health's products serve individuals seeking proactive mental wellness and those managing existing conditions. The company envisions a future where mental health support is universally accessible and deeply integrated into daily life. They aim to continuously refine their chat-based AI, ensuring solutions remain effective and user-friendly for a broad population.
Woebot Health has raised $122.5M across 3 funding rounds.
Woebot Health has raised $122.5M in total across 3 funding rounds.
Woebot Health is a technology company that builds an AI-powered mental health support platform designed to help people manage symptoms of anxiety, depression, and other emotional challenges through conversational, evidence-based therapeutic techniques. It primarily serves individuals in partnership with health plans, health systems, and virtual primary care providers, aiming to close gaps in mental healthcare access and ease clinician workload. Woebot’s product leverages clinically validated approaches like Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT), and Dialectical Behavioral Therapy (DBT) delivered via a friendly chatbot interface, making mental health support scalable and accessible. The company has shown strong growth momentum by expanding partnerships with healthcare organizations and pursuing FDA clearance for prescription digital therapeutics targeting postpartum depression and adolescent mental health[1][2][5].
Woebot Health was founded by Dr. Alison Darcy, a clinical research psychologist and health tech visionary, who developed the AI-driven mental health tool during her academic work at Stanford University. Motivated by the challenge that many people lack access to effective mental health treatments, Darcy created Woebot to provide scalable, accessible support. Early pivotal moments include multiple randomized controlled trials validating Woebot’s effectiveness and partnerships with payers and providers to scale its reach. The company’s evolution reflects a shift from public app access to integration within formal healthcare settings to maximize impact[5][1].
Woebot Health rides the growing trend of digital therapeutics and AI-driven mental health solutions, addressing a critical global need for accessible, scalable mental healthcare. The timing is favorable due to increasing mental health awareness, healthcare system strain, and advances in AI and digital health regulation. By embedding AI-powered therapy within formal healthcare, Woebot helps bridge the gap between demand and limited clinical resources, influencing the broader ecosystem by setting standards for evidence, privacy, and regulatory compliance in digital mental health[1][3][5].
Looking ahead, Woebot Health is positioned to expand its influence through FDA-approved prescription digital therapeutics and deeper integration with healthcare providers and payers. Trends such as personalized AI-driven care, regulatory acceptance of digital therapeutics, and growing mental health demand will shape its trajectory. Woebot’s commitment to scientific rigor and privacy will likely strengthen trust and adoption, potentially transforming mental health treatment delivery on a large scale. Its evolution from a public chatbot to a healthcare partner underscores a strategic focus on sustainable impact and clinical validation, promising a future where AI augments mental health care accessibility and effectiveness[1][2][3][5].
Woebot Health has raised $122.5M across 3 funding rounds. Most recently, it raised $9.5M Other Equity in March 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 15, 2022 | $9.5M Venture Round | Juergen Eckhardt | — | Announced |
| Jul 1, 2021 | $90M Series B | JAZZ Venture Partners, Temasek | Acadian Ventures, AI Fund, Album VC, Base Partners, DST Global, GSV Acceleration, Jump Capital, LearnStart, NEW Enterprise Associates, Hans Tung, OWL Ventures, Paradigm, Sapphire Ventures, Sequoia Capital China, Signal Peak Ventures, Chris Eyre, Alumni Ventures, BlackRock, Gaingels, Kicker Ventures, Mirae Asset Capital, NEA | Announced |
| Feb 1, 2018 | $23M Series A | NEW Enterprise Associates | AI Fund, Base Partners, DST Global, Hans Tung, Paradigm, Sequoia Capital China | Announced |
Woebot Health has raised $122.5M in total across 3 funding rounds.
Woebot Health's investors include Juergen Eckhardt, Jazz Venture Partners, Temasek, Acadian Ventures, AI Fund, Album VC, Base Partners, DST Global, GSV Acceleration, Jump Capital, LearnStart, New Enterprise Associates.